Plant Comparison

Purple coneflower vs Oregano

A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.

First plant
Second plant
Show:
Plant APurple coneflowerEchinacea purpureaAsteraceaeFull monograph →
Plant BOreganoOriganum vulgareLamiaceaeFull monograph →

At a glance

Purple coneflower and Oregano: they share 6 indicated uses (arthritis / joint pain, cold & flu, infection (general), …); 2 pharmacological actions in common.

Purple coneflowerOregano
Constituents32
Pharmacological actions36
Indicated uses79
Safety notes22
Cited sources1913
Indicated uses
Only Purple coneflower
Immune support
Shared (6)
Arthritis / joint painCold & fluInfection (general)Inflammation (general)Skin irritationWounds
Only Oregano
BloatingCoughIndigestion
Pharmacological actions
Only Purple coneflower
Immunomodulator / immune support
Shared (2)
Anti-inflammatoryAntimicrobial
Only Oregano
AntifungalAntioxidantCarminativeDigestive aid

Evidence face-off — shared uses

ConditionPurple coneflowerOreganoVerdict
Arthritis / joint pain1/102/10Comparable evidence
Cold & flu1/101/10Comparable evidence
Infection (general)1/103/10Stronger for Oregano
Inflammation (general)1/102/10Comparable evidence
Skin irritation1/103/10Stronger for Oregano
Wounds1/103/10Stronger for Oregano

Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.

Key Constituents

Alkamides[4]

Lipophilic alkamides are considered key immunomodulatory and anti-inflammatory constituents, particularly concentrated in the root.

Caffeic acid derivatives (echinacoside, cichoric acid)[4]

Antioxidant phenolic compounds contributing to the plant's immunomodulatory activity.

Caffeic acidPhenolic acids
Polysaccharides[4]

Water-soluble polysaccharides associated with immune-stimulating activity, particularly from the aerial parts.

Polysaccharides
Essential oil rich in carvacrol and thymol[1, 4, 6, 8, 11, 12]

Phenolic monoterpenes responsible for the strong antimicrobial activity.

Essential (volatile) oilTerpenes / terpenoidsCarvacrolThymol
Phenolic acids (rosmarinic acid) and flavonoids[11]

Antioxidant constituents.

Rosmarinic acidPhenolic acidsFlavonoids

Pharmacological Actions

Anti-inflammatory[4, 11, 15, 16, 17]
Antimicrobial[7, 8, 10, 15, 16, 17]
Immunomodulator / immune support[4, 5, 6, 8, 9, 15, 16, 17]
Anti-inflammatory[11, 12]

Antioxidant and anti-inflammatory

Antifungal[1, 11, 12, 13]

Antimicrobial (antibacterial and antifungal via carvacrol and thymol) - supports respiratory and gastrointestinal infections; a small clinical study found emulsified oregano oil cleared enteric parasites (incl. Blastocystis hominis) and improved gut symptoms

Antimicrobial[2, 5, 6, 7, 9, 10, 11, 12, 13]

Antimicrobial (antibacterial and antifungal via carvacrol and thymol) - supports respiratory and gastrointestinal infections; a small clinical study found emulsified oregano oil cleared enteric parasites (incl. Blastocystis hominis) and improved gut symptoms

Antioxidant[3, 9, 11, 12]

Antioxidant and anti-inflammatory

Carminative[11]

Carminative digestive for indigestion (traditional bitter aromatic)

Digestive aid[2, 11]

Carminative digestive for indigestion (traditional bitter aromatic)

Traditional & Indicated Uses

Arthritis / joint pain[15, 16, 17]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Arthritis / joint pain
Cold & flu[15, 16, 17]Traditional · 1/10

inferred from immunomodulator action

Evidence: 1
Label: Cold & flu
Immune support[15, 16, 17]Traditional · 1/10
Evidence: 1
Label: Immune support
Infection (general)[15, 16, 17]Traditional · 1/10

inferred from antimicrobial action

Evidence: 1
Label: Infection (general)
Inflammation (general)[15, 16, 17]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Inflammation (general)
Skin irritation[15, 16, 17]Traditional · 1/10

inferred from anti-inflammatory action

Evidence: 1
Label: Skin irritation
Wounds[15, 16, 17]Traditional · 1/10

inferred from antimicrobial action

Evidence: 1
Label: Wounds
Arthritis / joint pain[11, 12]Traditional · 2/10

inferred from anti-inflammatory action

Evidence: 2
Label: Arthritis / joint pain
Bloating[11]Traditional · 1/10

inferred from carminative action

Evidence: 1
Label: Bloating
Cold & flu[11]Traditional · 1/10

Aromatic support for coughs and colds (traditional)

Evidence: 1
Label: Cold & flu
Cough[11]Traditional · 1/10

Aromatic support for coughs and colds (traditional)

Evidence: 1
Label: Cough
Indigestion[11]Traditional · 1/10

Carminative digestive for indigestion (traditional bitter aromatic)

Evidence: 1
Label: Indigestion
Infection (general)[11, 12, 13]Limited · 3/10

Antimicrobial (antibacterial and antifungal via carvacrol and thymol) - supports respiratory and gastrointestinal infections; a small clinical study found emulsified oregano oil cleared enteric parasites (incl. Blastocystis hominis) and improved gut symptoms

Evidence: 3
Label: Infection (general)
Inflammation (general)[11, 12]Traditional · 2/10

inferred from anti-inflammatory action

Evidence: 2
Label: Inflammation (general)
Skin irritation[11, 12, 13]Limited · 3/10

inferred from antifungal action

Evidence: 3
Label: Skin irritation
Wounds[11, 12, 13]Limited · 3/10

inferred from antimicrobial action

Evidence: 3
Label: Wounds

Safety, Cautions & Contraindications

Safety note[15, 16, 17]Caution

Generally considered safe, but caution advised for those with autoimmune conditions. Not recommended for long-term use (more than 8 weeks continuously).

Safety note[15, 16, 17, 18]Caution

Duke (2002) rates echinacea as +++ — among the most thoroughly documented herbal immunostimulants. It notes experimental and clinical evidence for immunostimulant, antiviral, and anti-inflammatory activities. Multiple species have been studied (E. purpurea, E. angustifolia, E. pallida), and Duke emphasizes that species identification in commercial products is often unreliable. Commission E approves E. purpurea for supporting immune function during colds and flu. Dose: 900 mg standardized extract daily in acute use; use should be limited to 8 weeks continuous. Contraindicated in autoimmune diseases (MS, lupus, HIV/AIDS), tuberculosis, and with immunosuppressive drugs (cyclosporine) (Duke, 2002).

Safety note[12]Caution

Culinary amounts are safe. Concentrated oregano essential oil is a strong irritant - dilute well before any topical use and do not take undiluted oil internally.

Safety note[11]Caution

May lower blood sugar and has a mild antiplatelet effect, so use caution with antidiabetic or anticoagulant medicines; avoid medicinal/oil doses in pregnancy. Allergy is possible in people sensitive to the mint family (Lamiaceae).

External Ids

Gbif: 3150935
Powo: urn:lsid:ipni.org:names:1174497-2
Wikidata: Q272661
Gbif: 2926612
Wikidata: Q134283

Botanical Description

Robust perennial herb with a basal rosette of coarse, hairy, lance-shaped leaves and tall, sturdy flowering stems. Each stem bears a single large, daisy-like flower head with drooping (reflexed), rose-purple to pink ray florets surrounding a prominent, spiny, orange-brown central cone of disc florets.[4]

Height: 60-150 cm
Habit: Robust, clump-forming perennial herb
Leaves: Coarse, hairy, lance-shaped, in a basal rosette
Flowers: Large daisy-like heads with drooping rose-purple ray florets around a spiny orange-brown cone
Stem: Tall, sturdy, hairy, mostly unbranched
Root: Thick, fibrous, black-brown taproot
Fruit: Small four-angled achene
Flowering Period: June-September

Perennial herb/subshrub (Lamiaceae), 20-80 cm tall, with square, often reddish, downy stems. Leaves are opposite, ovate and aromatic. Small purplish-pink (occasionally white) flowers are borne in dense, flattened, corymb-like clusters at the branch tips.[11]

Height: 20-80 cm
Habit: Bushy, aromatic perennial herb/subshrub
Leaves: Opposite, ovate, aromatic
Flowers: Small, purplish-pink (occasionally white), in dense corymb-like terminal clusters
Stem: Square, often reddish, downy
Root: Fibrous, spreading perennial rootstock
Fruit: Four small nutlets (typical Lamiaceae schizocarp)
Flowering Period: July-September

Habitat

Native to the tallgrass prairies, open woodland and dry meadows of central and eastern North America; widely cultivated worldwide as a garden and medicinal plant.[4]

Native to the Mediterranean, Europe and temperate Asia and widely naturalised elsewhere, growing on dry, sunny grassland, banks and scrubby hillsides, typically on calcareous soils.[11]

Harvesting

The flower heads are picked as they open, in summer; the root is dug in autumn from plants at least two to three years old, when its content of bioactive alkamides and caffeic acid derivatives is highest, then cleaned and dried.[4]

Parts: Flower, Root
Season: Flower in summer; root in autumn from mature plants

Aerial parts are cut at or just before flowering (mid- to late summer), when essential-oil (carvacrol/thymol) content peaks, then dried quickly in the shade.[4, 9]

Parts: Aerial parts (leaf, herb)
Season: Mid- to late summer, at or just before flowering

Traditional Uses

Echinacea root was widely used by Native American peoples as a remedy for infections, wounds, snakebite and toothache, and entered nineteenth-century Eclectic medicine as a broad anti-infective. It remains best known today, in standardised aerial-part or root extracts, as a supportive remedy for preventing and shortening the common cold and supporting immune function.[1, 4]

Oregano has a long Mediterranean culinary-medicinal tradition as an aromatic digestive bitter and antiseptic remedy for coughs, colds and infections. Modern research on its carvacrol- and thymol-rich essential oil strongly supports broad antibacterial, antifungal and antioxidant activity, consistent with these traditional uses.[11, 12]

Preparations

Standardised extract[1]

Fresh-pressed juice or standardised extract of the aerial parts or root, taken as tablets, drops or capsules at the first sign of a cold; the best-studied clinical form.

Infusion (tea)[11]

Dried herb steeped in hot water as a digestive, aromatic tea.

Essential oil (diluted, topical/aromatic)[12]

The most-studied form; concentrated oil is a strong irritant and must be well diluted before topical use and never taken undiluted internally.

Emulsified oil (oral, supervised)[13]

A small clinical study used an emulsified oregano oil preparation to clear enteric parasites and improve gut symptoms; oral use of concentrated oil should be supervised.

Dosage

Standardised extract[1]

Clinical trials for the common cold commonly use around 300-900 mg of standardised extract daily, started at the first sign of symptoms and continued for up to 7-10 days; continuous use beyond about 8 weeks is not recommended. Educational reference only, not a prescription.

Culinary/infusion use[12]

Culinary amounts (as a food seasoning or mild tea) are considered safe; concentrated essential oil should only be used well diluted and is not intended for undiluted internal use without professional guidance. Educational reference only, not a prescription.

References

REF-0797, REF-0798, REF-0799, REF-2011, REF-2012, REF-2013, REF-2014, REF-2015, REF-2016, REF-2017, REF-2018, REF-2019, REF-2020, REF-2021
REF-1447, REF-1448, REF-1449, REF-1450, REF-1451, REF-1452, REF-1453, REF-1454, REF-1455, REF-1456

Drug Class Interactions

Safety note[19]Caution
Drug Class: immunosuppressants
Mechanism: Echinacea can both stimulate immune activity and alter CYP3A/CYP1A2 enzymes, so it may reduce the effect or change the blood levels of immunosuppressant drugs such as ciclosporin and tacrolimus; use only under medical supervision after a transplant or with autoimmune therapy.
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-03

Not documented

Lookalikes Review

Outcome: none-known
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-07
Outcome: none-known
Reviewed By: Omnia Sana (owner-authorized)
Reviewed Date: 2026-07-07

References & Sources

  1. Karsch-Völk, M., Barrett, B., Kiefer, D., Bauer, R. et al (2014) 'Echinacea for preventing and treating the common cold', Cochrane Database of Systematic Reviews, 2(2), pp. CD000530. doi:10.1002/14651858.CD000530.pub3 Meta-analysis / review
    https://doi.org/10.1002/14651858.CD000530.pub3
  2. Kamin, W., Seifert, G., Zwiauer, K., Bonhoeffer, J. et al (2025) 'Phytotherapy for acute respiratory tract infections in children: a systematically conducted, comprehensive review', Frontiers in Pediatrics, 13, pp. 1423250. doi:10.3389/fped.2025.1423250 Meta-analysis / review
    https://doi.org/10.3389/fped.2025.1423250
  3. Fashner, J., Ericson, K. and Werner, S (2012) 'Treatment of the common cold in children and adults', American Family Physician, 86(2), pp. 153-159. Available at: https://pubmed.ncbi.nlm.nih.gov/22962927/ Traditional / reference
    https://pubmed.ncbi.nlm.nih.gov/22962927/
  4. Manayi, A., Vazirian, M. and Saeidnia, S (2015) 'Echinacea purpurea: Pharmacology, phytochemistry and analysis methods', Pharmacognosy Reviews, 9(17), pp. 63-72. doi:10.4103/0973-7847.156353 Meta-analysis / review
    https://doi.org/10.4103/0973-7847.156353
  5. Burlou-Nagy, C., Banica, F., Jurca, T., Vicas, L.G., Marian, E., Muresan, M.E., Bacskay, I., Kiss, R., Feher, P. and Pallag, A (2022) 'Echinacea purpurea (L.) Moench: Biological and Pharmacological Properties. A Review', Plants, 11(9), pp. 1244. doi:10.3390/plants11091244 Meta-analysis / review
    https://doi.org/10.3390/plants11091244
  6. Hall, H., Fahlman, M.M. and Engels, H.J (2007) 'Echinacea purpurea and mucosal immunity', International Journal of Sports Medicine, 28(9), pp. 792-797. doi:10.1055/s-2007-964895 Randomized trial
    https://doi.org/10.1055/s-2007-964895
  7. Ross, S.M (2016) 'Echinacea purpurea: A Proprietary Extract of Echinacea purpurea Is Shown to be Safe and Effective in the Prevention of the Common Cold', Holistic Nursing Practice, 30(1), pp. 54-57. doi:10.1097/HNP.0000000000000130 Meta-analysis / review
    https://doi.org/10.1097/HNP.0000000000000130
  8. Hudson, J.B (2011) 'Applications of the phytomedicine Echinacea purpurea (Purple Coneflower) in infectious diseases', Journal of Biomedicine & Biotechnology, 2012, pp. 769896. doi:10.1155/2012/769896 Meta-analysis / review
    https://doi.org/10.1155/2012/769896
  9. Mishima, S., Saito, K., Maruyama, H., Inoue, M., Yamashita, T., Ishida, T. and Gu, Y (2004) 'Antioxidant and immuno-enhancing effects of Echinacea purpurea', Biological & Pharmaceutical Bulletin, 27(7), pp. 1004-1009. doi:10.1248/bpb.27.1004 Preclinical
    https://doi.org/10.1248/bpb.27.1004
  10. Saunders, P.R., Smith, F. and Schusky, R.W (2007) 'Echinacea purpurea L. in children: safety, tolerability, compliance, and clinical effectiveness in upper respiratory tract infections', Canadian Journal of Physiology and Pharmacology, 85(11), pp. 1195-1199. doi:10.1139/Y07-103 Clinical study
    https://doi.org/10.1139/Y07-103
  11. Micheli, L., Maggini, V., Ciampi, C., Gallo, E., Bogani, P., Fani, R., Pistelli, L., Ghelardini, C., Di Cesare Mannelli, L., De Leo, M. and Firenzuoli, F (2022) 'Echinacea purpurea against neuropathic pain: Alkamides versus polyphenols efficacy', Phytotherapy Research, 37(5), pp. 1911-1923. doi:10.1002/ptr.7709 Preclinical
    https://doi.org/10.1002/ptr.7709
  12. Gholami, M., Amri, J., Pazhoohan, S. and Sadegh, M (2021) 'Anticonvulsive and anti-epileptogenesis effects of Echinacea purpurea root extract, an involvement of CB2 receptor', Journal of Complementary & Integrative Medicine, 19(4), pp. 879-886. doi:10.1515/jcim-2020-0219 Preclinical
    https://doi.org/10.1515/jcim-2020-0219
  13. Awortwe, C., Bruckmueller, H., Kaehler, M. and Cascorbi, I (2021) 'Interaction of Phytocompounds of Echinacea purpurea with ABCB1 and ABCG2 Efflux Transporters', Molecular Pharmaceutics, 18(4), pp. 1622-1633. doi:10.1021/acs.molpharmaceut.0c01075 Preclinical
    https://doi.org/10.1021/acs.molpharmaceut.0c01075
  14. Perry, N.B., van Klink, J.W., Burgess, E.J. and Parmenter, G.A (1997) 'Alkamide levels in Echinacea purpurea: a rapid analytical method revealing differences among roots, rhizomes, stems, leaves and flowers', Planta Medica, 63(1), pp. 58-62. doi:10.1055/s-2006-957605 Preclinical
    https://doi.org/10.1055/s-2006-957605
  15. Linde, K., Barrett, B., Wölkart, K., Bauer, R. and Melchart, D (2006) 'Echinacea for preventing and treating the common cold'. Traditional / reference
    https://scholar.google.com/scholar?q=Echinacea%20for%20preventing%20and%20treating%20the%20common%20cold
  16. Sharma, M., Schoop, R., Suter, A. and Schoop, W (2010) 'The possibility of prophylactic treatment of streptococcal pharyngotonsillitis with a standardized Echinacea preparation', 29(8), pp. 1025--1035. Traditional / reference
    https://scholar.google.com/scholar?q=The%20possibility%20of%20prophylactic%20treatment%20of%20streptococcal%20pharyngotonsillitis%20with%20a%20standardized%20Echinacea%20preparation
  17. World Health Organization (1999) 'WHO Monographs on Selected Medicinal Plants'. Traditional / reference
    https://scholar.google.com/scholar?q=WHO%20Monographs%20on%20Selected%20Medicinal%20Plants
  18. Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
    https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
  19. Gorski, J.C., Huang, S.M., Pinto, A., Hamman, M.A., Hilligoss, J.K., Zaheer, N.A., Desai, M., Miller, M. and Hall, S.D (2004) 'The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo', Clinical Pharmacology and Therapeutics, 75(1), pp. 89-100. doi:10.1016/j.clpt.2003.09.013 Clinical study
    https://doi.org/10.1016/j.clpt.2003.09.013
  1. Angiolella, L., Rojas, F., Mussin, J. and Giusiano, G (2023) 'Modulatory effect of Origanum vulgare essential oil and carvacrol on Malassezia spp. virulence factors', Medical Mycology, 61(3), pp. myad026. doi:10.1093/mmy/myad026 Preclinical
    https://doi.org/10.1093/mmy/myad026
  2. Veenstra, J.P. and Johnson, J.J (2019) 'Oregano (Origanum vulgare) extract for food preservation and improvement in gastrointestinal health', International Journal of Nutrition, 3(4), pp. 43-52. doi:10.14302/issn.2379-7835.ijn-19-2703 Preclinical
    https://doi.org/10.14302/issn.2379-7835.ijn-19-2703
  3. Stojanovic, N.M., Mitic, K.V., Nesic, M., Stankovic, M. and others (2024) 'Oregano (Origanum vulgare) Essential Oil and Its Constituents Prevent Rat Kidney Tissue Injury and Inflammation Induced by a High Dose of L-Arginine', International Journal of Molecular Sciences, 25(2), pp. 941. doi:10.3390/ijms25020941 Preclinical
    https://doi.org/10.3390/ijms25020941
  4. Mertzanidis, D., Nakas, A., Assimopoulou, A.N. and Kokkini, S (2023) 'Unravelling the Chemotaxonomic Identity of 'White' and 'Black' Oregano (Origanum vulgare) in Northern Greece', Planta Medica, 89(4), pp. 433-440. doi:10.1055/a-1949-8895 Preclinical
    https://doi.org/10.1055/a-1949-8895
  5. Kosakowska, O., Weglarz, Z., Styczynska, S., Synowiec, A. and others (2024) 'Activity of Common Thyme, Greek Oregano, and Common Oregano (Origanum vulgare) Essential Oils against Selected Phytopathogens', Molecules, 29(19), pp. 4617. doi:10.3390/molecules29194617 Preclinical
    https://doi.org/10.3390/molecules29194617
  6. Hou, H., Zhang, X., Zhao, T. and Zhou, L (2020) 'Effects of Origanum vulgare essential oil and its two main components, carvacrol and thymol, on a plant pathogen', PeerJ, 8, pp. e9626. doi:10.7717/peerj.9626 Preclinical
    https://doi.org/10.7717/peerj.9626
  7. Hao, Y., Li, J. and Shi, L (2021) 'A Carvacrol-Rich Essential Oil Extracted From Oregano (Origanum vulgare 'Hot & Spicy') Exerts Potent Antibacterial Effects', Frontiers in Microbiology, 12, pp. 741861. doi:10.3389/fmicb.2021.741861 Preclinical
    https://doi.org/10.3389/fmicb.2021.741861
  8. Baranauskaite, J., Jakstas, V., Ivanauskas, L., Kopustinskiene, D.M. and others (2016) 'Optimization of carvacrol, rosmarinic, oleanolic and ursolic acid extraction from oregano herbs (Origanum onites L., Origanum vulgare spp. hirtum and Origanum vulgare L.)', Natural Product Research, 30(6), pp. 672-674. doi:10.1080/14786419.2015.1038998 Preclinical
    https://doi.org/10.1080/14786419.2015.1038998
  9. Zinno, P., Guantario, B., Lombardi, G., Ranaldi, G. and others (2023) 'Chemical Composition and Biological Activities of Essential Oils from Origanum vulgare Genotypes Belonging to the Carvacrol and Thymol Chemotypes', Plants, 12(6), pp. 1344. doi:10.3390/plants12061344 Preclinical
    https://doi.org/10.3390/plants12061344
  10. Kolypetri, S., Kostoglou, D., Nikolaou, A., Kourkoutas, Y. and others (2023) 'Chemical Composition, Antibacterial and Antibiofilm Actions of Oregano (Origanum vulgare subsp. hirtum) Essential Oil against Salmonella Typhimurium and Listeria monocytogenes', Foods, 12(15), pp. 2893. doi:10.3390/foods12152893 Preclinical
    https://doi.org/10.3390/foods12152893
  11. Soltani, S., Shakeri, A., Iranshahi, M. and Boozari, M (2021) 'A Review of the Phytochemistry and Antimicrobial Properties of Origanum vulgare L. and Subspecies', Iranian Journal of Pharmaceutical Research. doi:10.22037/ijpr.2020.113874.14539 Traditional / reference
    https://doi.org/10.22037/ijpr.2020.113874.14539
  12. Sharifi-Rad, M., Varoni, E.M., Iriti, M., Martorell, M., Setzer, W.N., del Mar Contreras, M., Salehi, B., Soltani-Nejad, A., Rajabi, S., Tajbakhsh, M. and Sharifi-Rad, J (2018) 'Carvacrol and human health: A comprehensive review', Phytotherapy Research. doi:10.1002/ptr.6103 Preclinical
    https://doi.org/10.1002/ptr.6103
  13. Force, M., Sparks, W.S. and Ronzio, R.A (2000) 'Inhibition of enteric parasites by emulsified oil of oregano in vivo', Phytotherapy Research, 14(3), pp. 213--214. doi:10.1002/(SICI)1099-1573(200005)14:3<213::AID-PTR583>3.0.CO;2-U Clinical study
    https://doi.org/10.1002/(SICI)1099-1573(200005)14:3<213::AID-PTR583>3.0.CO;2-U

Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.